Lansoprazole degradation is accelerated in both acidic and basic medium in water. The present investigation deals with the hydrolytic degradation of Lansoprazole. Acidic medium degradation show all known impurities and degradation products whereas basic degradation studies show new impurity which has higher molecular weight than Lansoprazole. New impurity was identified, isolated using mass based auto purification system and characterised by 1 H NMR, 13 C NMR, HMBC, HSQC, NOE, COSY and HRMS experiments. Isolated impurity was showing molecular weight of 467.10, molecular formula of C 23 H 16 F 3 N 5 OS and its name is 7-(3-Methyl-4-(2,2,2-trifluoroethoxy) pyridin-2-yl)-7H-benzo[4,5]imidazo[2,1-b]benzo[4,5]imidazo[2,1-d][1,3,5]thiadiazine.
KeywordsLansoprazoleHydrolytic DegradationIsolationCharacterizationPreparative HPLC<sup>1</sup>H NMR<sup>13</sup>C NMR and 2 D NMR
Richter, J.E., Campbell, D.R., Kahrilas, P.J., Huang, B. and Fludas, C. (2000) Lansoprazole Compared with Ranitidine for the Treatment of Nonerosive Gastroesophageal Reflux Disease. Archives of Internal Medicine, 160, 1803-1809. http://dx.doi.org/10.1001/archinte.160.12.1803
Brummer, R.J., Geerling, B.J. and Stockbrugger, R.W. (1997) Initial and Chronic Gastric Acid Inhibition by Lansoprazole and Omeprazole in Relation to Meal Administration. Digestive Disease and Sciences, 42, 132-137.
Tang, G., Serfaty-Lacronsniere, C., Camilo, M.E. and Russell, R.M. (1996) Gastric Acidity Influences the Blood Response to a Beta-Carotene Dose in Humans. American Journal of Clinicle Nutrition, 64, 22-26.
Tolman, K.G., Sanders, S.W., Buchi, K.N., Karol, M.D., Jennings, D.E. and Ringham, G.L. (1997) The Effects of Oral Doses of Lansoprazole and Omeprazole on Gastric pH. Journal of Clinicle Gastroenterology, 24, 65-70. http://dx.doi.org/10.1097/00004836-199703000-00003
Fitton, A. and Wiseman, L. (1996) Pantoprazole: A Review of Its Pharmacological Properties and Therapeutic Use in Acid-Related Disorders. Drugs, 51, 460-482. http://dx.doi.org/10.2165/00003495-199651030-00012
Matheson, A.J. and Jarvis, B. (2001) Lansoprazole: An Update of Its Place in the Management of Acid-Related Disorders. Drugs, 61, 1801-1833. http://dx.doi.org/10.2165/00003495-200161120-00011
Nudelman, N.S. and Estabilidad de (1975) Medicamentos. EI Ateno, Buenos Aires.
Kommanaboyina, B. and Rhodes, C.T. (1999) Trends in Stability Testing, with Emphasis on Stability during Distribution and Storage. Drug Development and Industrial Pharmacy, 25, 857-868. http://dx.doi.org/10.1081/DDC-100102246
Karljikovic-Rajic, K., Novovic, D., Marinkovic, V. and Agbaba, D. (2003) Journal of Pharmaceutical and Biomedical Analysis, 32, 1019-1027.
Anil Kumar, A., Venkata Ramana, K., Narasimha Raju, C.H. and Sudhakara Rao, G. (2012) A Simple UV Spectrophotometric Method for Determination of Lansoprazole in Bulk and Pharmaceutical Dosage Forms. International Journal of Pharmaceutical, Chemical and Biological Sciences, 2, 524-528.
Alagar raja, M., Yadav, S.K., Rai, A. and Mishra, S. (2011) Analytical Estimation of Lansoprazole and Validation of Simple Spectrophotometric in Bulk and Capsule Formulation. International Journal of Research in Pharmaceutical Sciences, 2, 521-524.
Okram, Z.D., Kanakapura, B., Jagannathamurthy, R.P. and Basavaiah, V.K. (2012) Development of a Simple UV-Spectrophotometric Method for the Determination of Lansoprazole and Study of Its Degradation Profile. Química Nova, 35, 386-391. http://dx.doi.org/10.1590/S0100-40422012000200027
Rao, P.V., Kumar, M.N. and Kumar, M.R. (2013) A Novel, Validated Stability-Indicating UPLC Method for the Estimation of Lansoprazole and Its Impurities in Bulk Drug & Pharmaceutical Dosage Forms. Scientia Pharmaceutica, 81, 183-193. http://dx.doi.org/10.3797/scipharm.1210-09
Al-Momani, I.F. and Rababah, M.H. (2010) Validation of HPLC and FIA Spectrophotometric Methods for the Determination of Lansoprazole in Pharmaceutical Dosage Forms and Human Plasma. American Journal of Analytical Chemistry, 1, 34-39. http://dx.doi.org/10.4236/ajac.2010.11005
Muthu Kumar, S., Selva Kumar, D., Raj Kumar, T., Udhaya Kumar, E., Suba Geetha, A. and Diwedi, D. (2010) Development and Validation of RP-HPLC Method for the Estimation of Lansoprazole in Tablet Dosage Form. Journal of Chemical and Pharmaceutical Research, 2, 291-295.
Luo, Y.F., Xu, L.S., Xu, M., Feng, J. and Tang, X. (2012) A Validated Specific, Stability Indicating HPLC Method for Determination of Lansoprazole Enteric Coated Capsules and Related Impurities. Asian Journal of Pharmaceutical Sciences, 7, 149-154.
Patel, B., Dedani, Z., Dedani, R., Ramolia, C., Sagar, V. and Mehta, R.S. (2009) Simultaneous Estimation of Lansoprazole and Domperidone in Combined Dosage Form by RP-HPLC. Asian Journal of Research in Chemistry, 2, 210-212.
Brown, S.D., Connor, J.D., Smallwood, N.C. and Lugo, R.A. (2011) Quantification of Lansoprazole in Oral Suspension by Ultra-High-Performance Liquid Chromatography Hybrid Ion-Trap Time-of-Flight Mass Spectrometry. International Journal of Analytical Chemistry, 2011, Article ID: 832414. http://dx.doi.org/10.1155/2011/832414
Katsuki, H., Hamada, A., Nakamura, C., Arimori, K. and Nakano, M. (2011) High-Performance Liquid Chromatographic Assay for the Simultaneous Determination of Lansoprazole Enantiomers and Metabolites in Human Liver Microsomes. Journal of Chromatography B, 757, 127-133. http://dx.doi.org/10.1016/S0378-4347(01)00135-9
Cirilli, R., Ferretti, R., Gallinella, B., Turchetto, L., Zanitti, L. and La Torre, F. (2009) Development and Validation of an Enantioselective and Chemoselective HPLC Method Using a Chiralpak IA Column to Simultaneously Quantify(R)-(+)- and (S)-(?)-Lansoprazole Enantiomers and Related Impurities. Journal of Pharmaceutical and Biomedical Analysis, 50, 9-14. http://dx.doi.org/10.1016/j.jpba.2009.03.021
Petkovska, R., Cornett, C. and Dimitrovska, A. (2008) Chemometrical Approach in Lansoprazole and Its Related Compounds Analysis by Rapid Resolution RP-HPLC Method. Journal of Liquid Chromatography & Related Technologies, 31, 2159-2173. http://dx.doi.org/10.1080/10826070802225478
Srinivas, K.S.V., Mukkanti, K., Buchireddy, R. and Srinivasulu, P. (2010) Detection, Isolation and Characterisation of Principal Synthetic Route Indicative Impurity in Lansoprazole. E-Journal of Chemistry, 7, 844-848.
Reddy, G.M., Mukkanti, K., Laxmi Kumar, T., Moses Babu, J. and Reddy, P.P. (2008) Synthesis and Characterization of Metabolites and Potential Impurities of Lansoprazole, an Antiulcerative Drug. Synthetic Communications, 38, 3477-3489. http://dx.doi.org/10.1080/00397910802162934
Ramulu, K., Rao, B.M. and Someswara Rao, N. (2013) Identification, Isolation and Characterization of Potential Degradation Product in Lansoprazole Drug Substance. Rasayan Journal of Chemistry, 6, 274-283.